Protein-conjugated acrolein as a biochemical marker of brain infarction
✍ Scribed by Kazuei Igarashi; Keiko Kashiwagi
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 396 KB
- Volume
- 55
- Category
- Article
- ISSN
- 1613-4125
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The relationship between acrolein (CH~2~=CH‐CHO) and brain infarction is the focus of this review. It has been found that acrolein is produced mainly within cells from polyamines by polyamine oxidases (PAOs), especially from spermine by spermine oxidase during cell damage, and that acrolein is more toxic than reactive oxygen species (ROS) in a cell culture system. Thus, the possibility that acrolein and PAOs are good biochemical markers of stroke was tested because there are no other reliable biochemical markers at the early stage of stroke. Levels of protein‐conjugated acrolein (PC‐Acro) and PAOs (acrolein‐producing enzymes) were significantly increased in the plasma of stroke patients. The multiplied value of PC‐Acro by PAOs was nearly parallel with the size of stroke. Furthermore, when the combined measurements of PC‐Acro, interleukin‐6 (IL‐6) and C‐reactive protein (CRP) were evaluated along with age using a receiver operating characteristic (ROC) curve, even silent brain infarction (SBI), which is a small brain infarction, was indicated with approximately 84% sensitivity and specificity. These findings clearly indicate that acrolein is strongly correlated with cell damage during brain infarction.